Hypervisor IX Monitoring System

K150632 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · MSX · Jul 6, 2015 · Cardiovascular

Device Facts

Record IDK150632
Device NameHypervisor IX Monitoring System
ApplicantShenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product CodeMSX · Cardiovascular
Decision DateJul 6, 2015
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2300
Device ClassClass 2
AttributesPediatric

Intended Use

The indications for use of the Hypervisor IX Monitoring System include: · Real time viewing of patient clinical data and alarms · Storage and Historical review of patient clinical data and alarms · Printing of real time and historical patient data · Configuration of local settings as well as synchronizing settings across the network to a remote device · Transfer of patient clinical data and settings between several CentralStations The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wireless WiFi (WLAN), and Wireless WMTS. The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors. The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm. · The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016. • The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The Centralstation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608. · The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The physiological data can be reviewed locally on the transmitter. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60. The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner.

Device Story

Networked patient monitoring system for hospital/clinical use; receives physiological data (ECG, SpO2, heart rate, pulse rate) from compatible Mindray monitors via Ethernet, WiFi, or WMTS; central station displays, stores, prints, and transfers data; supports bi-directional configuration of connected monitors; includes telemetry subsystems (TMS-6016, Telepack-608, TMS60); clinicians use system for real-time viewing and historical review of patient data/alarms; facilitates clinical decision-making through centralized monitoring and alarm management; benefits patients by enabling continuous remote surveillance.

Clinical Evidence

Bench testing only. Functional and system-level testing performed to evaluate performance differences and ensure compliance with consensus standards. Wireless functionality testing conducted to verify performance against specifications.

Technological Characteristics

Networked patient monitoring system; OS: Microsoft Windows 7 Professional Embedded SP1; Connectivity: Ethernet 802.3, WiFi (WLAN), WMTS (608M range); Hardware: HP/Kontron workstations; Software: Mindray/Mortara ECG algorithms; Features: Arrhythmia detection, ST segment analysis, QT analysis, J-point auto-detection, QRS thresholding; Supports drug, hemodynamics, oxygenation, ventilation, and renal calculations.

Indications for Use

Indicated for adult and pediatric patients in hospital/clinical settings for remote monitoring of ECG, SpO2, heart rate, pulse rate, arrhythmia, QT, and ST segment analysis via networked physiological monitors.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized graphic of three human profiles facing right, stacked on top of each other. The profiles are rendered in a dark color, creating a silhouette effect. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the graphic. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 July 6, 2015 Shenzhen Mindray Bio-medical Electronics Co., Ltd Yanhong Bai Manager Regulatory Affairs Mindray Building, Kenji 12th Road South, Hi-tech Industrial Park, Nanshan Shenzhen, 518057 CN Re: K150632 Trade/Device Name: Hypervisor IX Monitoring System Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer and Rate Alarm) Regulatory Class: Class II Product Code: MSX, MHX, DRQ Dated: March 9, 2015 Received: March 11, 2015 Dear Yanhong Bai: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply {1}------------------------------------------------ with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K150632 Device Name Hypervisor IX Monitoring System #### Indications for Use (Describe) - The indications for use of the Hypervisor IX Monitoring System include: - · Real time viewing of patient clinical data and alarms - · Storage and Historical review of patient clinical data and alarms - · Printing of real time and historical patient data - · Configuration of local settings as well as synchronizing settings across the network to a remote device - · Transfer of patient clinical data and settings between several CentralStations The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wireless WiFi (WLAN), and Wireless WMTS. The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors. The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm. · The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016. • The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The Centralstation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608. · The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The physiological data can be reviewed locally on the transmitter. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60. The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner. Type of Use (Select one or both, as applicable) X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. {3}------------------------------------------------ This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ # 510(K) SUMMARY In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the Hypervisor IX Monitoring System is provided below. | Device Common Name: | Physiological Monitors, Network and Communication<br>System | |----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Trade Name: | Hypervisor IX Monitoring System | | Applicant: | SHENZHEN MINDRAY BIO-MEDICAL<br>ELECTRONICS CO., LTD.<br>Mindray Building, Keji 12th Road South<br>High-tech Industrial Park, Nanshan<br>Shenzhen 518057, P.R. China<br>Tel: +86 755 81885635<br>Fax: +86 755 26582680 | | Contact: | Yanhong Bai<br>Manager Regulatory Affairs<br>SHENZHEN MINDRAY BIO-MEDICAL<br>ELECTRONICS CO., LTD.<br>Mindray Building, Keji 12th Road South<br>High-tech Industrial Park, Nanshan 518057, P.R. China<br>Tel: +86 755 81885635<br>Fax: +86 755 26582680<br>E-mail: baiyanhong@mindray.com | | Prepared by: | Donna-Bea Tillman, Ph.D.<br>Biologics Consulting Group, Inc.<br>400 N. Washington St, Suite 100<br>Alexandria, VA 22314<br>Phone: 410-531-6542<br>Email: dtillman@bcg-usa.com | | Date Prepared: | March 20, 2015 | | Classification Regulation: | 870.2300 - Cardiac Monitor (including cardiotachometer and<br>rate alarm)<br>Class II | | Panel: | Cardiovascular | | Product Code: | MSX - Physiological Monitors Network and<br>Communication System | | Subsequent Product Codes: | DRQ- Transducer signal amplifier and conditioner | | | MHX - Arrhythmia detector and alarm (including ST-<br>segment measurement and alarm) | {5}------------------------------------------------ #### K132036 – Hypervisor Central Monitoring System Predicate Device: #### Indication for Use: The indications for use of the Hypervisor IX Monitoring System include: - Real time viewing of patient clinical data and alarms ● - Storage and Historical review of patient clinical data and alarms ● - Printing of real time and historical patient data ● - Configuration of local settings as well as synchronizing settings across the network to a remote device - Transfer of patient clinical data and settings between several CentralStations ● The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS. The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors. The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm. - . The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016. - . The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608. - The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ● ECG and SpO2 physiological data. The physiological data can be reviewed locally on the display of the transmitter. The CentralStation will support ECG, Heart Rate, {6}------------------------------------------------ SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60. The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner. ## Device Description: The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS. The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors. The Hypervisor IX Monitoring System includes three telemetry monitoring systems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm. The Hypervisor IX Monitoring System consists the following components: - 1. Central Station - 2. View Station - 3. Work Station - 4. Telemetry Systems (TMS 6016, Telepak-608, TMS60) ## Performance Data: - . To establish the substantial equivalence of the Hypervisor IX Monitoring System, Mindray conducted functional and system level testing on the subject device. The testing provided an evaluation of the performance of the device relevant to each of the differences between the subject device and the predicate device. The functional and system level testing showed that the devices continue to meet specifications and the performance of the device is equivalent to the predicate. - Mindray has conducted testing to ensure the subject device meets relevant consensus standards. - . Mindray conducted Wireless functionality testing to ensure the performance of the Hypervisor IX Monitoring System meets wireless specifications and is equivalent to the predicate device. - Mindray has followed the following FDA Guidance Documents relevant to this device: {7}------------------------------------------------ - । Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm Guidance for Industry and FDA (10/28/2003) - Cardiac Monitor Guidance (Including Cardiotachometer and Rate Alarm) । - Class II Special Controls Guidance Document: Electrocardiograph Electrodes । ### Comparison of Technological Characteristics: The technological characteristics of the subject device are compared to the predicate device in the table below. | | Predicate Device | Subject Device | | | |------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name | HYPERVISOR CENTRAL<br>MONITORING SYSTEM (INCLUDING<br>TELEMETRY MONITORING SYSTEM,<br>TMS-6016) | Hypervisor IX Monitoring System | | | | Manufacturer | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD | SHENZHEN MINDRAY BIO-MEDICAL<br>ELECTRONICS CO., LTD | | | | 510(k) | K132036 | TBD | | | | Regulation | 870.2300 - Cardiac Monitor (including<br>cardiotachometer and rate alarm)<br>Class II | 870.2300 - Cardiac Monitor (including<br>cardiotachometer and rate alarm)<br>Class II | | | | Product Code | MSX - Physiological Monitors Network<br>and Communication System | MSX - Physiological Monitors Network<br>and Communication System | | | | Operating<br>System | Windows XP Professional Embedded SP3 | Microsoft Windows 7 Professional<br>Embedded SP1 | | | | Network<br>Configuration | 100 Mbps, Ethernet 802.3 | Same | | | | Host<br>Computers | HP Compaq 8380 Elite MT | HP Compaq 8380 Elite MT<br>HP EliteDesk 800 G1 SFF<br>Kontron KISS 2U V2 KTQ87FLEX | | | | Patient<br>Monitor<br>Numbers | Up to 16 monitors in the single-screen<br>mode and 32 monitors in the dual- or<br>multi-screen mode simultaneously<br>Support up to four local displays | Same | | | | | Predicate Device | Subject Device | | | | Patient<br>Monitor<br>Connectivity | Supports the following patient monitors:<br>DPM3 (K072235)<br>DPM4/5 (K070791)<br>DPM6/7 (K092449)<br>Passport 12M/17M (K143195)<br>Passport8/12 (K132662)<br>Accutorr 7 (K132038)<br>T1 (K143195) | Supports the following patient monitors:<br>DPM3 (K072235)<br>DPM4/5 (K070791)<br>DPM6/7 (K092449)<br>Passport 12M/17M (K143195)<br>Passport8/12 (K132662)<br>Accutorr 7 (K132038)<br>T1 (K143195)<br>Spectrum (K062098)<br>Spectrum OR (K062098)<br>Passport II (K020550)<br>Passport V (K091834)<br>V12/21 (K132026) | | | | | Telemetry<br>System | TMS-6016 (K132036) | TMS-6016 (K132036)<br>Telepack-608 (K142601)<br>TMS60 | | | | | Calculations | Supports five calculation modes:<br>Drug Calculation<br>Hemodynamics Calculation<br>Oxygenation Calculation<br>Ventilation Calculation<br>Renal Calculation | No change | | | | | Remote<br>Monitoring | Provided on supported monitors | | | Data Review<br>Features | | Dynamic short trend<br>Trend review<br>Wave review<br>NIBP review<br>Event Review<br>12-lead review<br>ST review<br>Cardiac output review<br>Print and Display<br>Records | Dynamic short trend<br>Trend review<br>Wave review<br>NIBP review<br>Event Review<br>12-lead review<br>ST review<br>Cardiac output review<br>Print and Display (now includes QT View)<br>Records | | | | | Predicate Device | Subject Device | | | ECG Features | | Mindray or Mortara ECG Algorithms -<br>selectable | Mindray or Mortara ECG Algorithms -<br>selectable | | | | | 3-lead or 5-lead selectable | 3-lead or 5-lead selectable | | | arrhythmia detection | arrhythmia detection with adjustable leads | | | | | ST segment analysis | ST segment analysis | | | | | heart rate | heart rate | | | | | Pace Mark | Pace Mark | | | | | Pace Pulse Rejection | Pace Pulse Rejection | | | | | | QT Analysis | | | | | | J Point Auto detection | | | | | | QRS Detection Threshold | | | #### Device Comparison Table {8}------------------------------------------------ {9}------------------------------------------------ ## Comparison of Indications: The indication for use statement of the Hypervisor IX Monitoring System includes the indication for the system as whole as well as cleared indications for each of the components of the system. Both the predicate device and the subject device are patient monitoring systems intended to be used in healthcare facilities under the direction of clinical professionals. Additional language has been added to the indications for use of the current device to more clearly describe existing functions, as well as to include the new feature of OT monitoring. Although QT monitoring was not included in the predicate Hypervisor device, it is present in the cleared Philips ST/AR ST and Arrhythmia Software (K101521), and thus does not constitute a new intended use for a patient monitoring system. ## Substantial Equivalence Conclusion: Based on the detailed comparison of specifications for each of the modifications to the previously cleared Hypervisor Central Monitoring System, the functional and performance testing and conformance with applicable standards as well as the comparison of indications, the differences do not raise new questions of safety and effectiveness and the Hypervisor IX Monitoring System can be found substantially equivalent to the predicate device.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%